MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Press releases

Displaying 11..20 of 746 - per page Previous page Next page
Order by
The eighth BioBusiness Asia conference, a two-day gathering of life science business professionals from around Asia held annually in Taipei, Taiwan, opened its doors today. More
BIOMEDICA FOSCAMA's leading drug Esafosfina® has been acknowledged as a safe and effective phosphorus source in total parenteral nutrition More
Astorg Partners announces today the acquisition of the Groupe Ethypharm. More
Research being driven by The University of Western Ontario to enhance diabetes management across Canada has received $500,000 from two of Canada's leading pharmaceutical companies. More
"MENOPUR(tm) is at least as effective and well tolerated as genetically-engineered, so called recombinant FSH in women undergoing in-vitro fertilisation treatment" More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
Merz Pharma KGaA, specializing in the treatment of diseases of the central nervous system and of esthetic dermatology, has received approval for the first-ever pure botulinum toxin type A (BoNT/A). More
First pharma partnering conference to let registrants determine the event's focus. Automatic evaluation and display of delegates' interests. More
New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More
Displaying 11..20 of 746 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us